PharmaBoardroom

Regulatory, Pricing and Reimbursement Overview: Nigeria

The key facts about regulation, pricing and reimbursement in Nigerian Pharma. Prepared in association with Olaniwun Ajayi LP, a leading law firm in…

Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Argentina

Key legal info on cannabinoid drugs, medicinal cannabis and opioid drugs in Argentina. Prepared in association with Marval, O’Farrell & Mairal,…

US FDA’s Efforts to Advance the Development of Gene Therapy

Peter Marks, director of the US FDA's Center for Biologics Evaluation and Research, outlines how the organization is attempting to further promote the…

Shirley Xu – President Greater China, Baxter

Shirley Xu, president of Baxter Greater China, reflects on her extraordinary 26-year (and counting) career with Baxter China, including her…

Hungary’s National Champions Betting on Biosimilars

Hungary’s two largest pharma firms, Egis Pharmaceuticals and Gedeon Richter, are stepping up their biosimilars offering; providing the European…

Iliette Frontera – VP Operations, Boston Scientific Puerto…

Iliette Frontera, VP Operations of Boston Scientific in Puerto Rico, shares the significance of the Dorado site within the group’s global supply…

Shinsuke Yuasa – President, Thai Otsuka

Shinsuke Yuasa, president of Thai Otsuka discusses the importance of Thailand for Otsuka as its first overseas market back in 1973. Yuasa goes on to…

Vatroslav Mateljic – General Manager, Takeda Sweden

Originally from Croatia, Vatroslav Mateljic was appointed as the general manager of Takeda Sweden in April 2019. Mateljic outlines how Takeda is…

Peter Zerhouni – CEO, InDex Pharmaceuticals, Sweden

InDex Pharmaceuticals is a Swedish biopharma company developing drugs that could help patients suffering from ulcerative colitis, an inflammatory…

Switzerland: Fresh Tactics in the War on Cancer

With cancer now causing one in eight deaths globally and, in Europe, even outpacing serious cardiovascular conditions in terms of prevalence,…

Legacy Healthcare: Countering A Silent Pandemic

Worldwide, severe side effects from classic medicine are becoming a health risk in themselves, often misdiagnosed as symptoms of other problems,…

Chinese Pharma Legal Update: October 2019

Fangda Partners' Josh Shin gives an overview of recent regulatory upgrades affecting the Chinese pharmaceutical industry. On August 26,…

Tagged with EG